We are live on ! Find out more
Syncona Portfolio

Syncona Portfolio Portfolio holdings

AUM $32.3M Turnover 0%
1-Year Est. Return 51.22%
This Fund
S&P 500
This Quarter Est. Return
-21.87%
1 Year Est. Return
+51.22%
3 Year Est. Return
+24.03%
5 Year Est. Return
-64.76%
10 Year Est. Return
–
AUM
$70.4M
AUM Growth
-$34.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACHL
1
DELISTED
Achilles Therapeutics
ACHL
$27.9M 39.7%
11,086,909
– –
2021 Q4
2 quarters
AUTL icon
2
Autolus Therapeutics
AUTL
$242M
$20.8M 29.54%
7,346,829
– –
2021 Q4
2 quarters
FRLN
3
DELISTED
Freeline Therapeutics Holdings
FRLN
$19.3M 27.43%
1,466,508
– –
2021 Q4
2 quarters
ADAP
4
DELISTED
Adaptimmune Therapeutics
ADAP
$2.34M 3.33%
1,377,294
– –
2021 Q4
2 quarters

Similar funds

Syncona Portfolio's Q2 2022 Portfolio in Review

As of Q2 2022, Syncona Portfolio held 4 positions worth $70.4M, down 33% from $105M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Syncona Portfolio opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's ten largest holdings make up 100% of its $70.4M portfolio in Q2 2022.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q2 2022.
  • Syncona Portfolio's portfolio value fell 33% quarter-over-quarter to $70.4M.

Based on Syncona Portfolio's 13F filing for Q2 2022, filed 10 Aug 2022.